MedPath

ALCON RESEARCH

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Comparison of Two Marketed Silicone Hydrogel Lenses

Not Applicable
Completed
Conditions
Refractive Error
Interventions
Device: Lotrafilcon B contact lenses
Device: Samfilcon A contact lenses
Device: Hydrogen peroxide solution
Device: Saline solution
First Posted Date
2015-07-13
Last Posted Date
2016-12-28
Lead Sponsor
Alcon Research
Target Recruit Count
168
Registration Number
NCT02495948

Proof of Concept Study to Evaluate Safety and Efficacy of LME636 in the Treatment of Acute Anterior Uveitis

Phase 2
Completed
Conditions
Acute Anterior Uveitis
Interventions
Drug: Dexamethasone 0.1% ophthalmic solution
Drug: LME636 60 mg/mL ophthalmic solution
Drug: LME636 Vehicle
First Posted Date
2015-06-26
Last Posted Date
2018-07-02
Lead Sponsor
Alcon Research
Target Recruit Count
45
Registration Number
NCT02482129

Clinical Comparison of 27+® and 23-gauge ULTRAVIT® 7500 Cpm Vitrectomy Outcomes

Not Applicable
Completed
Conditions
Vitreoretinal Disease
Interventions
Device: CONSTELLATION® 27-gauge Combined Surgical Pak
Device: CONSTELLATION® 23-gauge Combined Surgical Pak
Procedure: Vitrectomy surgery
First Posted Date
2015-06-23
Last Posted Date
2018-07-02
Lead Sponsor
Alcon Research
Target Recruit Count
137
Registration Number
NCT02477605
Locations
🇺🇸

Contact Alcon Call Center for Trial Locations, Fort Worth, Texas, United States

Evaluation of Clinical Outcomes After the Use of SYSTANE® HYDRATION

Not Applicable
Completed
Conditions
Dry Eye
Interventions
Device: SYSTANE HYDRATION lubricant eye drops
Device: Hyabak 0.15% eye drops
Drug: 0.9% saline eye drops
First Posted Date
2015-06-12
Last Posted Date
2018-07-02
Lead Sponsor
Alcon Research
Target Recruit Count
114
Registration Number
NCT02470429

Clinical Evaluation Following Use of SYSTANE® ULTRA in the Management of Dry Eye

Not Applicable
Completed
Conditions
Dry Eye Syndrome
Interventions
First Posted Date
2015-05-15
Last Posted Date
2018-07-02
Lead Sponsor
Alcon Research
Target Recruit Count
159
Registration Number
NCT02446015

Safety and Efficacy of EXE844 Otic Suspension in Otitis Media at Time of Tympanostomy Tube Insertion (OMTT) - Study 2

Phase 3
Completed
Conditions
Otitis Media With Effusion in Children
Otitis Media Recurrent
Interventions
Drug: EXE844 Sterile Otic Suspension, 0.3%
Procedure: Tympanostomy Tube Insertion
First Posted Date
2015-05-06
Last Posted Date
2018-07-02
Lead Sponsor
Alcon Research
Target Recruit Count
404
Registration Number
NCT02436304

Efficacy and Safety of RTH258 Versus Aflibercept - Study 2

Phase 3
Completed
Conditions
Neovascular Age-Related Macular Degeneration
Choroidal Neovascularization
Interventions
First Posted Date
2015-05-05
Last Posted Date
2020-09-11
Lead Sponsor
Alcon Research
Target Recruit Count
1048
Registration Number
NCT02434328

Safety and Efficacy of EXE844 Otic Suspension in Otitis Media at Time of Tympanostomy Tube Insertion (OMTT)

Phase 3
Completed
Conditions
Otitis Media With Effusion in Children
Otitis Media Recurrent
Interventions
Drug: EXE844 Sterile Otic Suspension, 0.3%
Procedure: Tympanostomy Tube Insertion
First Posted Date
2015-05-01
Last Posted Date
2018-07-02
Lead Sponsor
Alcon Research
Target Recruit Count
470
Registration Number
NCT02432105

SIMBRINZA® Suspension BID as an Adjunctive to Prostaglandin Analogue (PGA)

Phase 4
Completed
Conditions
Open-Angle Glaucoma
Ocular Hypertension
Interventions
Drug: Brinzolamide 1%/brimonidine 0.2% tartrate ophthalmic suspension
Drug: Brinz/brim vehicle
Drug: Prostaglandin analogue
First Posted Date
2015-04-17
Last Posted Date
2018-11-15
Lead Sponsor
Alcon Research
Target Recruit Count
290
Registration Number
NCT02419508
Locations
🇺🇸

Contact Alcon Call Center for Trial Locations, Fort Worth, Texas, United States

Clear Care® Plus vs. PeroxiClear™

Not Applicable
Completed
Conditions
Refractive Error
Interventions
Device: Clear Care Plus contact lens solution
Device: PeroxiClear contact lens solution
Device: Silicone hydrogel contact lenses
First Posted Date
2015-04-09
Last Posted Date
2016-09-19
Lead Sponsor
Alcon Research
Target Recruit Count
133
Registration Number
NCT02413333
© Copyright 2025. All Rights Reserved by MedPath